4//SEC Filing
Horn Kinney 4
Accession 0001415889-22-001314
CIK 0001750284other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:18 PM ET
Size
8.9 KB
Accession
0001415889-22-001314
Insider Transaction Report
Form 4
Horn Kinney
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2022-02-10$2.06/sh+5,251$10,838→ 7,709 total - Disposition to Issuer
Common Stock
2022-02-10−5,251→ 2,458 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-02-10−5,251→ 147,038 totalExercise: $2.06Exp: 2030-11-09→ Common Stock (5,251 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- [F2]The weighted average sale price for the transaction reported was $5.46, and the range of prices were between $5.14 and $5.66. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date.
Documents
Issuer
Olema Pharmaceuticals, Inc.
CIK 0001750284
Entity typeother
Related Parties
1- filerCIK 0001831215
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:18 PM ET
- Size
- 8.9 KB